ArticleRespirology (Carlton, Vic.)2020
The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.
Article in Respirology (Carlton, Vic.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.PloS one · 2025Article
- A multicentre study comparing post-mortem SARS-CoV-2 antibody testing in Cape Town mortuaries.Southern African journal of infectious diseases · 2025Article
- Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers.GeroScience · 2024Article
- Article
- Longitudinal Characterization of a Neutralizing and Total Antibody Response in Patients with Severe COVID-19 and Fatal Outcomes.Vaccines · 2022Article
- Antibody Dependent Enhancement of SARS-CoV-2 Infection in the Era of Rapid Vaccine Development.Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022Review
- COVID-19 patients exhibit unique transcriptional signatures indicative of disease severity.Frontiers in immunology · 2022Article
- Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.Frontiers in immunology · 2022Article
- Clinical relevance of SARS-CoV-2 infection in late pregnancy.BMC pregnancy and childbirth · 2021Article
- Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects.Analytical and bioanalytical chemistry · 2021Review
- Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.Journal of advanced research · 2021Review
- Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan.Journal of medical virology · 2021Article
- The challenge of avidity determination in SARS-CoV-2 serology.Journal of medical virology · 2021Article
- Article
- Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection.Scandinavian journal of immunology · 2021Article
- Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.PloS one · 2021Article
- Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays.Pathology · 2020Article
- Microfluidic immunoassay for detection of serological antibodies: A potential tool for rapid evaluation of immunity against SARS-CoV-2.Biomicrofluidics · 2020Review
- SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy.medRxiv : the preprint server for health sciences · 2020Article
- The role of SARS-CoV-2 antibodies in COVID-19: Healing in most, harm at times.Respirology (Carlton, Vic.) · 2020Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.